Registration link: https://www.eventbrite.com/e/genobiotx-monthly-webinar-tickets-1053785844829 Date: Wednesday, Oct 30th, 2024; 11:00 am PDT, or 2:00 pm EDT Webinar Highlights: This seminar will introduce GenoBioTX’s gene editing platform and technology, highlighting how these techniques can enhance your research projects. We will cover the history of genome editing, provide an overview of GenoBioTX’s gene editing platform and technology, and present […]
Registration link: https://us06web.zoom.us/webinar/register/WN_zp48kyBhSH2rHpm_adFNIw Date: Thursday, Aug 28th, 2024; 2:00 pm EDT or 11:00 am PDT Webinar Highlights: This webinar will explore various methods for generating monoclonal antibodies, emphasizing the challenges of producing high-affinity antibodies to self or highly homologous antigens. Traditional methods, like in vitro screening and hybridoma-derived antibodies post-immunization, are cost-effective but struggle with […]
Aclidineleukin (high-dose IL-2) is the first FDA-approved cancer immunotherapy for metastatic renal cell carcinoma (RCC) and melanoma, but the widespread clinical use of aclidinein has been limited by its short half-life, serious side effects, and simultaneous stimulation of Treg activation. With the breakthrough of studies of immune checkpoint inhibitors, IL-2-based therapeutics has regained widespread attention, […]
We provide gene editing techniques such as CRISPR/Cas9, transgenic approaches, or gene knockout strategies.
Researchers can request specific modifications to evaluate phenotypic changes, drug responses, or genetic interactions, facilitating the advancement of biomedical research and therapeutic developments.
Please fill in the order form and we will contact you within 2 working days.
